Pure D-Chiro-Inositol Powder High Quality for Pcos Support Ovarian Function Hormone Balance

Name: Pure D-Chiro-Inositol Powder High Quality for Pcos Support Ovarian Function Hormone Balance
Brand: Shanghai Beimoo Biotechnology Co., Ltd.
SKU: 1992292991

Shanghai, ChinaShanghai Beimoo Biotechnology Co., Ltd.

US$445.00

1-49 kg

US$435.00

50+ kg

Sample price:US$445.00/kg.Request sample

Product profile

Customization

Available

CAS No.

643-12-9

Formula

C6h12o6

Model NO.

99% Purity D-Chiro-Inositol (DCI) Powder

Packaging Material

Package

Storage Method

Sealed, Dry, Cool Place

Shelf Life

24 Months

Nutrient Composition

Vitamin B Group Nutrient

Resource

Natural

The content of active substances

98%,99%

CAS Number

643-12-9

Appearance

White Crystalline Powder

Grade

Food Grade

Package

Bulk Package

Test

HPLC

Sample

Available

Purity

≥98% (HPLC) / ≥99% (Customizable)

Solubility

Soluble in Water

Application

Dietary Supplement, Pcos Support, Functional Food

Certificate

ISO,Kosher,Halal

Transport Package

1kg/Bag 25kg/Drum

Specification

98%, 99%

Trademark

Beimoobio

Origin

China

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryLow MOQ

Shanghai Beimoo Biotechnology Co., Ltd.

Shanghai, China

Business Type: Trading Company CertifiedCustomization Options: Full Customization, Flexible customization, etc. CertifiedNearest Port: Shanghai PortAverage Response Time: ≤4.54h CertifiedTerms of Payment: LC, T/T, D/P, etc. CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR, EXW

AI-Powered supplier vetting

SummaryThe supplier operates across biotechnology, food ingredients, health products, cosmetics, agricultural products, machinery, electrical equipment, hardware, and related goods. It reports quality assurance and documented finished-product inspection instructions, as well as full, minor, and flexible customization. Export sales account for 90% of total sales, but the supplier began exporting only one year ago and has no overseas warehouse, showroom, agents, branches, or offline trade-show participation. Service-management weaknesses include no written procedures or records for supplier service assessment, corrective and preventive actions, or complaint handling, and no approved-supplier list. The supplier describes an R&D team and synthetic-biology focus, but reports no ODM, SDK, or well-known-brand OEM capability. Financial information provided shows zero stated revenue, profit, cost, cash inflows, and cash outflows for the referenced periods, which does not support financial credibility.

Supplier typeThe supplier is positioned as a biotechnology and food-ingredient producer, with stated activities covering plant-based food ingredients, functional health-product raw materials, cosmetic actives, food processing, daily chemicals, agricultural products, machinery, electrical equipment, hardware, and office supplies. Its declared scope is therefore diversified across biological products, food-related goods, and equipment-related trading or sales activities.

After-Sales capabilityThe supplier has no written procedures or records for service-capability assessment, corrective and preventive actions, or effective customer-complaint handling, and has no approved-supplier list. It also reports no overseas warehouse, showroom, overseas agent or branch, and no offline trade-show participation, indicating limited documented service infrastructure and overseas support channels.

Financial creditThe provided financial records state zero operating revenue, operating costs, gross profit, operating profit, cash inflows, and cash outflows for the referenced periods, with current ratios also stated as zero. These figures do not provide evidence of stable financial operations or sufficient financial credibility.

R&D capabilityThe supplier describes a world-class R&D team, experts from an advanced biological laboratory, and advanced synthetic-biology techniques for developing plant-based ingredients, health-product raw materials, and cosmetic actives. However, it reports no ODM service and no available SDK, so innovation evidence is stronger in biotechnology R&D positioning than in broader development-service offerings.

Production capacityThe supplier states that its products are manufactured across food, healthcare, pharmaceutical, cosmetics, and animal-nutrition applications, and that finished products are inspected using documented instructions that are uniformly followed. Quality assurance is also explicitly reported, supporting production and quality-control capability, although no capacity, facility, or output-volume data is provided.

Customization capabilityThe supplier explicitly offers full customization, minor customization, and flexible customization, and describes customized solutions for client-specific specifications. This is direct evidence of a broad customization offering.